DiaSorin
Employees
View Company Info for Free
Overview
Website
diasoringroup.comRevenue
-
ZI Rank: 12
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
8
10
11
12
DiaSorin Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DiaSorin your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if DiaSorin has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on DiaSorin recently announced quarterly report
Check out if DiaSorin is spiking on competitors!
Click to see if DiaSorin had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at DiaSorin
DiaSorin, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when DiaSorin launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once DiaSorin has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
DiaSorin financials insights
Gather financial insights about DiaSorin, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$31M
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
DiaSorin News & Media
DiaSorin S.p.A. (DSRLF) Q2 2024 Earnings Call Transcript
DiaSorin S.p.A. (OTCPK:DSRLF) Q2 2024 Earnings Conference Call July 29, 2024 11:00 AM ETCompany ParticipantsCarlo Rosa - Chief Executive OfficerPiergiorgio...DiaSorin S.p.A. (DSRLF) Q4 2023 Earnings Call Transcript
DiaSorin S.p.A. (OTCPK:DSRLF) Q4 2023 Earnings Conference Call March 15, 2024 10:00 AM ETCompany ParticipantsCarlo Rosa - Chief Executive OfficerPiergiorgio...DiaSorin S.p.A. (DSRLF) Q3 2023 Earnings Call Transcript
DiaSorin S.p.A. (OTCPK:DSRLF) Q3 2023 Earnings Conference Call November 3, 2023 11:30 AM ETCompany ParticipantsCarlo Rosa - Chief Executive...Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has completed the sale of substantially all of its assets related to the Flow Cytometry & Imaging (FCI) business unit to Cytek for approximately USD 46.5 million.
Read more news
Frequently Asked Questions Regarding DiaSorin
Sign Up For FreeTo access detailed company insights
